GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rapport Therapeutics Inc (NAS:RAPP) » Definitions » Total Operating Expense

RAPP (Rapport Therapeutics) Total Operating Expense : $83.06 Mil (TTM As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Rapport Therapeutics Total Operating Expense?

Rapport Therapeutics's Total Operating Expense for the three months ended in Dec. 2024 was $23.52 Mil. Rapport Therapeutics's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 was $83.06 Mil.

Rapport Therapeutics Total Operating Expense Historical Data

The historical data trend for Rapport Therapeutics's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rapport Therapeutics Total Operating Expense Chart

Rapport Therapeutics Annual Data
Trend Dec22 Dec23 Dec24
Total Operating Expense
- 36.18 83.06

Rapport Therapeutics Quarterly Data
Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Operating Expense Get a 7-Day Free Trial Premium Member Only 14.79 17.09 20.80 21.64 23.52

Rapport Therapeutics Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $83.06 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rapport Therapeutics Total Operating Expense Related Terms

Thank you for viewing the detailed overview of Rapport Therapeutics's Total Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Rapport Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rapport Therapeutics Inc (NAS:RAPP) » Definitions » Total Operating Expense
Comparable Companies
VSTM ALT TECX ZVRA ERAS ORKA SANA ABSI CELC ORIC VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
1325 Boylston Street, Suite 401, Boston, MA, USA, 02215
Website
https://www.rapportrx.com
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.